Clinical Trial Update: Observational Study of Correction of Anaemia With Darbepoetin Alfa at QM Dosing Interval in Patients With CKD Not on Dialysis

View source ↗

Summary

An observational study assessing correction of anemia with monthly darbepoetin alfa in patients with chronic kidney disease not on dialysis. The study has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• darbepoetin alfa (darbepoetin alfa)

Snippet

Sponsor: Amgen | Conditions: Anaemia, Chronic Kidney Disease (CKD) | Status: COMPLETED